本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Epizyme Inc.

1.47
0.0000
成交量:- -
成交額:3,275.66萬
市值:2.47億
市盈率:-0.91
高:1.47
開:1.47
低:1.47
收:1.47
資料載入中...
2021/02/23

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/23

重要事件披露

8-K - Current report
2020/11/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/06

重要事件披露

8-K - Current report
2020/10/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/04

重要事件披露

8-K - Current report
2020/06/03

重要事件披露

8-K - Current report
2020/05/04

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/04

重要事件披露

Current report, items 2.02 and 9.01
2020/04/03

重要事件披露

8-K - Current report
2020/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/24

重要事件披露

Current report, items 2.02 and 9.01
2020/02/21

超過5%披露

[Amend] General statement of acquisition of beneficial ownership